Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France

AstraZeneca

Status: Completed

Conditions: Breast Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT00681369

NIS-OFR-FAS-2007/1

Details and patient eligibility

About

the purpose of this study is to describe the way Faslodex is used in France, in patients suffering from initial breast cancer, that is to evaluate Faslodex treatment duration and to determine patients profile

Enrollment: 217 patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients suffering from initial breast cancer, treated with Faslodex, treatment which was stopped during 2007

Trial design

217 participants in 1 patient group

1

Description:

Patients suffering from initial breast cancer, treated with Faslodex, treatment which was stopped during 2007